27
Jan
2010
Posted in I - Series C, Q - 4Q09, R - WEST, X - Device (Neuromod), XX - CA
EmSense (San Francisco, CA) a commercial-stage device company focused on cognitive neuroscience, analytics, and market research through a wireless, scalable, non?invasive EEG neuroscience technology, closed a $9M Series C financing. Participants include Technology Partners and Foundry Group.
Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb